The Role of NT-proBNP as a Biomarker in Evaluating Residual Cardiovascular Risk in 200 Type 2 DM Patients Optimized for Conventional CV Risk Markers over Two Years

被引：0
|
作者：
Gupta, Vishal
Teli, Vaishali
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1513-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 29 条
  • [1] To Evaluate Patient Characteristics in Those with Elevated NT-proBNP in Type 2 DM Patients Optimized for Conventional CV Risk Factors on Standard Care for Two Years
    Gupta, Vishal
    Teli, Vaishali
    DIABETES, 2018, 67
  • [2] To evaluate the relationship between HSCRP and NT-proBNP in 200 type 2 diabetes patients optimised for conventional cardiovascular and renal risk factors at the end of 2 years
    Gupta, V.
    Teli, V.
    DIABETOLOGIA, 2019, 62 : S542 - S542
  • [3] Rationale for the testingof cardiovascular risk in patients with COX-2 inhibitors with the biomarker NT-proBNP
    Giannitsis, E
    CLINICAL LABORATORY, 2005, 51 (1-2) : 73 - 83
  • [4] Rationale for testing the cardiovascular risk for patients with COX-2 inhibitors on the basis of biomarker NT-proBNP
    Giannitsis, E
    CLINICAL LABORATORY, 2005, 51 (1-2) : 63 - 72
  • [5] NT-proBNP, a risk marker for cardiac events in patients over 75 years.
    Resl, Michael
    Neuhold, Stephanie
    Riedl, Michaela
    Abrahamian, Heidemarie
    Prager, Rudolf
    Pacher, Richard
    Huelsmann, Martin
    Luger, Anton
    Clodi, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (17-18) : A6 - A6
  • [6] NT-proBNP is a Risk marker for Cardiac events in Patients over75 Years.
    Resl, Michael
    Neuhold, Stephanie
    Elhenicky, Marie
    Riedl, Michaela
    Abrahamian, Heidemarie
    Prager, Rudolf
    Pacher, Richard
    Huelsmann, Martin
    Luger, Anton
    Clodi, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S23 - S23
  • [7] NT-proBNP by Itself Predicts Death and Cardiovascular Events in High-Risk Patients With Type 2 Diabetes Mellitus
    Malachias, Marcus V. B.
    Jhund, Pardeep S.
    Claggett, Brian L.
    Wijkman, Magnus O.
    Bentley-Lewis, Rhonda
    Chaturvedi, Nishi
    Desai, Akshay S.
    Haffner, Steven M.
    Parving, Hans-Henrik
    Prescott, Margaret F.
    Solomon, Scott D.
    De Zeeuw, Dick
    McMurray, John J., V
    Pfeffer, Marc A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (19):
  • [8] Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    Suriya Prausmüller
    Michael Resl
    Henrike Arfsten
    Georg Spinka
    Raphael Wurm
    Stephanie Neuhold
    Philipp E. Bartko
    Georg Goliasch
    Guido Strunk
    Noemi Pavo
    Martin Clodi
    Martin Hülsmann
    Cardiovascular Diabetology, 20
  • [9] Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
    Prausmueller, Suriya
    Resl, Michael
    Arfsten, Henrike
    Spinka, Georg
    Wurm, Raphael
    Neuhold, Stephanie
    Bartko, Philipp E.
    Goliasch, Georg
    Strunk, Guido
    Pavo, Noemi
    Clodi, Martin
    Huelsmann, Martin
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [10] NT-PROBNP AND HSTNT IMPROVE CARDIOVASCULAR RISK PREDICTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS, CHRONIC KIDNEY OR CARDIOVASCULAR DISEASE OR BOTH
    Jhund, Pardeep
    Claggett, Brian
    Pfeffer, Marc
    Bentley-Lewis, Rhonda
    Brenner, Barry M.
    Brunel, Patrick
    Chaturvedi, Nishi
    Desai, Akshay
    Haffner, Steven
    Parving, Hans-Henrik
    Prescott, Margaret
    Solomon, Scott
    De Zeeuw, Dick
    McMurray, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A1279 - A1279
123